← All stocks

Eledon Pharmaceuticals, Inc.

ELDN No buying or selling
CIK 0001404281 #3653 in the set updated 21 Sep 2026
Bought (1 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (1 mo)
$0.00
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$0.00
0 of 0 sales
Net
$0.00
$0.00 against sales at will

By person

8 insiders · 0 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Gros David-Alexandre C
Chief Executive Officer
168,663
$438.00K
+1,774%
Perrin Steven
President
81,215
$210.91K
+8,022%
Katkin Keith
Director
8,575
$22.27K
Robinson James A. Jr.
Director
3,430
$8.91K
McBride John S.
Director
3,430
$8.91K
Hillson Jan
Director
3,430
$8.91K
Kirk Allan
Director
3,430
$8.91K
Lee June
Director
3,430
$8.91K

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.

Nothing of that kind in this period.

What was left out

Form 4 filings counted 0
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 0
History held since 11 May 2017